The topline. San Juan, October 23, 2026. Whole genome sequencing has become a routine diagnostic tool, and genetic screening of healthy people keeps spreading. Yet until now nobody had described what an average human genome actually looks like. A team led by the University of Exeter has answered, surveying nearly one million whole-genome sequences from the UK Biobank and the U.S. All of Us program and presenting the work at the American Society of Human Genetics meeting. Their answer is both ordinary and startling: variation is the norm, and everyone is carrying something.

Key facts

The numbers come from the paper published in Genome Medicine this week. The average genome carries about 5 million variants, places where one person’s DNA differs from another’s. Around 10,000 of those alter gene sequences, effects that range from lactose intolerance to drug response but are usually biologically neutral.

The disease-relevant slice is small but universal. Every person carries between one and three rare variants previously shown to cause serious genetic diseases, plus about 50 rare variants currently of uncertain clinical relevance. On polygenic risk scores across 28 common conditions, from diabetes to schizophrenia, most people would be categorized as high genetic risk for about three of them.

The study also counted the new mutations each of us carries that appear in neither parent: about 63 on average, arising mostly in the father’s sperm and some in the mother’s eggs, rising by roughly 1.2 additional mutations per year of paternal age. The researchers did not check participants’ health status, deliberately: the point is that these findings are part of normal variation, not diagnoses.

Clinical relevance

This is a calibration tool, not a scare. As senior author Caroline Wright puts it, everyone could be told they are at genetic risk for numerous conditions based on genetics alone, which is exactly why context matters: symptoms, family history, and clinical and environmental factors decide what a finding means. For physicians ordering panels, interpreting results, or counseling families, the paper supplies the denominator that has been missing. It also gives screening programs a baseline for deciding what to report and what not to escalate. One caveat to carry: both biobanks skew toward Western European ancestry, and the authors flag the need for more diverse data before this average is truly average.

5 million

That is the number of variants in a typical human genome, the background noise against which every clinical genetic result must be read. The number that matters most in the exam room may be the smaller one: three. Three serious-disease variants of known effect, fifty of uncertain relevance, and high polygenic risk for three common conditions, in a person with no symptoms at all. When a report flags something frightening, the question is not whether the variant exists. It is whether, in this patient, it means anything.

What we’re reading

  • Genome Medicine: the full paper, with the variant counts and methods.
  • UK Biobank: the population cohort behind half the sequences.
  • All of Us: the U.S. cohort behind the other half.
  • Medical Xpress: the October 22 summary of the findings.